2023 - Research.com Microbiology in United States Leader Award
The scientist’s investigation covers issues in Immunology, Virology, Acquired immunodeficiency syndrome, Internal medicine and Viral load. His research in Immunology intersects with topics in Raltegravir, Pharmacotherapy and Semen. Joseph J. Eron combines subjects such as Viral disease, Asymptomatic and Blood plasma with his study of Acquired immunodeficiency syndrome.
The Internal medicine study combines topics in areas such as Gastroenterology and Surgery. His work investigates the relationship between Viral load and topics such as Rilpivirine that intersect with problems in Cabotegravir. His studies examine the connections between Lamivudine and genetics, as well as such issues in Reverse-transcriptase inhibitor, with regards to Nevirapine.
Joseph J. Eron spends much of his time researching Internal medicine, Immunology, Virology, Viral load and Acquired immunodeficiency syndrome. His work deals with themes such as Gastroenterology and Lamivudine, which intersect with Internal medicine. In his study, Semen is strongly linked to Sexual transmission, which falls under the umbrella field of Immunology.
His study in Drug resistance extends to Virology with its themes. His Viral load research incorporates elements of RNA, Adverse effect, Pharmacotherapy and Emtricitabine, Antiretroviral therapy. His Acquired immunodeficiency syndrome research is multidisciplinary, relying on both Viral disease, Clinical trial, Immunopathology and Confidence interval.
Joseph J. Eron focuses on Internal medicine, Viral load, Antiretroviral therapy, Cohort and Acquired immunodeficiency syndrome. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Tenofovir alafenamide and Emtricitabine. His research investigates the link between Viral load and topics such as Proportional hazards model that cross with problems in Stroke.
His biological study spans a wide range of topics, including Viremia, Immunology and Virology. His Immunology study integrates concerns from other disciplines, such as Cytotoxic T cell, Adverse effect and In vivo. His Virology study combines topics from a wide range of disciplines, such as Drug resistance and Provirus.
Joseph J. Eron mainly focuses on Internal medicine, Acquired immunodeficiency syndrome, Antiretroviral therapy, Cohort and Viral load. Joseph J. Eron interconnects Tenofovir alafenamide, Cobicistat and Emtricitabine in the investigation of issues within Internal medicine. His studies deal with areas such as Observational study, Absolute risk reduction, Confidence interval, Regimen and Disease as well as Acquired immunodeficiency syndrome.
He has researched Antiretroviral therapy in several fields, including Viremia, Peripheral blood mononuclear cell, Intensive care medicine and Virology. His Viremia study is concerned with the larger field of Immunology. His Viral load study often links to related topics such as Young adult.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble.
The New England Journal of Medicine (2011)
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
Scott M. Hammer;Kathleen E. Squires;Michael D. Hughes;Michael D. Hughes;Janet M. Grimes.
The New England Journal of Medicine (1997)
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
R M Gulick;J W Mellors;D Havlir;J J Eron.
The New England Journal of Medicine (1997)
Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel
Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy.
JAMA (2008)
Effect of early versus deferred antiretroviral therapy for HIV on survival.
Mari M. Kitahata;Stephen J. Gange;Alison G. Abraham;Barry Merriman.
The New England Journal of Medicine (2009)
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble.
The New England Journal of Medicine (2016)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin;A. L. Liberty;A. D. Kashuba;S. K. Choudhary.
Nature (2012)
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.
Jacob P. Lalezari;Keith Henry;Mary O'Hearn;Julio S.G. Montaner.
The New England Journal of Medicine (2003)
Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1
Myron S Cohen;Irving F Hoffman;Rachel A Royce;Peter Kazembe.
The Lancet (1997)
Brief but efficient: acute HIV infection and the sexual transmission of HIV.
Christopher D. Pilcher;Hsiao Chuan Tien;Joseph J. Eron;Pietro L. Vernazza.
The Journal of Infectious Diseases (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Johns Hopkins University
University of Alabama at Birmingham
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill
Harvard University
University of Alabama at Birmingham
University of North Carolina at Chapel Hill
Fenway Health
The Ohio State University
University of Pittsburgh
University of Toledo
Johannes Kepler University of Linz
University of Cyprus
Shanghai Jiao Tong University
Active Layer Parametrics
University of Glasgow
Durham University
Lawrence Livermore National Laboratory
University of Colorado Boulder
University of Rochester
Victoria University
Kumamoto University
McGill University
University of Michigan–Ann Arbor
Sorbonne University
Princeton University